Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Z-D-SER-OBZL is a peptide chemical compound composed of the amino acid serine (SER) attached to a dipeptide of tyrosine (Y) and phenylalanine (F) in a specific configuration. It is known for its potential biological activities, such as mimicking natural peptides and influencing cellular signaling pathways. Z-D-SER-OBZL has been studied for its potential therapeutic properties in various medical conditions, including cancer, inflammation, and neurological disorders, making it a promising candidate for further investigation and therapeutic development.

53933-06-5

Post Buying Request

53933-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53933-06-5 Usage

Uses

Used in Pharmaceutical Research and Development:
Z-D-SER-OBZL is used as a research compound for its potential biological activities, particularly in mimicking natural peptides and influencing cellular signaling pathways. This makes it a valuable tool in drug development for various medical conditions.
Used in Cancer Therapy:
Z-D-SER-OBZL is used as a potential therapeutic agent in cancer treatment. Its ability to influence cellular signaling pathways may contribute to the inhibition of tumor growth and progression, offering a novel approach to cancer therapy.
Used in Inflammation Management:
Z-D-SER-OBZL is used as a potential anti-inflammatory agent. Its influence on cellular signaling pathways may help in reducing inflammation and managing inflammatory conditions.
Used in Neurological Disorders:
Z-D-SER-OBZL is used as a potential therapeutic agent in the treatment of neurological disorders. Its potential to influence cellular signaling pathways may contribute to the management and treatment of various neurological conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 53933-06-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,9,3 and 3 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53933-06:
(7*5)+(6*3)+(5*9)+(4*3)+(3*3)+(2*0)+(1*6)=125
125 % 10 = 5
So 53933-06-5 is a valid CAS Registry Number.

53933-06-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl (2R)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoate

1.2 Other means of identification

Product number -
Other names Z-D-SERINE-OBZL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53933-06-5 SDS

53933-06-5Relevant articles and documents

Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine

Sayama, Misa,Uwamizu, Akiharu,Ikubo, Masaya,Chen, Luying,Yan, Ge,Otani, Yuko,Inoue, Asuka,Aoki, Junken,Ohwada, Tomohiko

, p. 10059 - 10101 (2021/07/28)

Three human G protein-coupled receptors (GPCRs)—GPR34/LPS1, P2Y10/LPS2, and GPR174/LPS3—are activated specifically by lysophosphatidylserine (LysoPS), an endogenous hydrolysis product of a cell membrane component, phosphatidylserine (PS). LysoPS consists of-serine, glycerol, and fatty acid moieties connected by phosphodiester and ester linkages. We previously generated potent and selective GPCR agonists by modification of the three modules and the ester linkage. Here, we show that a novel modification of the hydrophilic serine moiety, that is, N-acylations of the serine amine, converted a GPR174 agonist to potent GPR174 antagonists. Structural exploration of the amide functionality provided access to a range of activities from agonist to partial agonist to antagonist. The present study would provide a new strategy for the development of lysophospholipid receptor antagonists.

Synthesis method and application of 1-aza -5-germanium-5-alkyl bicyclic [3.3.3] undecane compound.

-

Paragraph 0216; 0221, (2020/05/11)

The invention provides a 1-aza-5-germanium hetero-5-alkyl bicyclic [3.3.3] hendecane compound having a structure shown in the formula I, and the types of the 1-aza-5-germanium hetero-5-alkyl bicyclic[3.3.3] hendecane compound are expanded. The provided compound can serve as a nucleophilic reagent, the air and humidity conditions of the nucleophilic reagent are stable, and the efficiency of the Ge-Stille coupling reaction of aryl halogen and the 1-aza-5-germanium hetero-5-alkyl bicyclic [3.3.3] hendecane compound is high.

Toward aplyronine payloads for antibody-drug conjugates: Total synthesis of aplyronines A and D

An?i?ek, Nika,Williams, Simon,Housden, Michael P.,Paterson, Ian

supporting information, p. 1343 - 1350 (2018/03/06)

The aplyronines are a family of antimitotic marine macrolides that disrupt cytoskeletal dynamics by dual targeting of both actin and tubulin. Given their picomolar cytotoxicity profile and unprecedented mode of action, the aplyronines represent an excellent candidate as a novel payload for the development of next-generation antibody-drug conjugates (ADCs) for cancer chemotherapy. Enabled by an improved second-generation synthesis of the macrolactone core 5, we have achieved the first total synthesis of the most potent congener aplyronine D together with a highly stereocontrolled synthesis of aplyronine A. To facilitate step economy, an adventurous site-selective esterification of the C7 hydroxyl group was performed to install the N,N,O-trimethylserine pharmacophore to directly afford aplyronines A and D. Toward the assembly of ADCs incorporating an aplyronine warhead, the C29-ester derivative 4 featuring an Fmoc-amino substituted linker attached to the actin-binding tail region was also prepared by adapting this flexible endgame.

NOVEL COMPOUNDS

-

Page/Page column 49-50, (2016/02/26)

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, (formula 1) wherein R1,R2, R3, R4, R5, X, m and n are defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

A practical decarboxylative hydroxylation of carboxylic acids

Barton, Derek H. R.,Gero, Stephane D.,Holliday, Pascale,Quiclet-Sire, Beatrice,Zard, Samir Z.

, p. 6751 - 6756 (2007/10/03)

Irradiation of esters of N-hydroxy-2-thiazolinethione under air or oxygen at room temperature in the presence of tert-dodecanethiol affords the corresponding nor-alcohols after a reductive work-up.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53933-06-5